$CELG Recent Headlines Why speculators see opportunity

New Post Public Reply Private Reply Replies (0) Message Board

Jan 6, 2015 at 10:44 AM

$CELG Recent Headlines

Why speculators see opportunity in younger, cyclical stocks 2:50 p.m. Dec. 26, 2014 - The Trading Deck
GoPro, Gilead Sciences, Celgene gain 11:28 a.m. Dec. 26, 2014 - MarketWatch
Dow ekes out gain for 37th record close of 2014 2:56 p.m. Dec. 24, 2014 - Anora Mahmudova
GoPro, Adamas climb, Cal-Maine slides 10:06 a.m. Dec. 24, 2014 - MarketWatch
Cal-Maine Foods shares fall on earnings miss 4:41 p.m. Dec. 23, 2014 - Wallace Witkowski
A teachable moment: Here are my worst stock picks of 2014 10:19 a.m. Dec. 23, 2014 - Jeff Reeves
Four signs that would indicate a new uptrend 2:52 p.m. Dec. 16, 2014 - The Trading Deck
Liquid growth stocks tell interesting tale 3:11 p.m. Dec. 9, 2014 - The Trading Deck
H&R Block shares fall on quarterly miss 6:42 p.m. Dec. 8, 2014 - Wallace Witkowski
The S&P 500 recorded its biggest drop in nearly 7 weeks 4:33 p.m. Dec. 8, 2014 - Anora Mahmudova
Celgene shares climb 1.9% 9:31 a.m. Dec. 8, 2014 - Sue Chang
Is the next Cisco out there? 3:24 p.m. Nov. 25, 2014 - The Trading Deck
5 charts show how stock repurchases boost prices 6:00 a.m. Nov. 18, 2014 - Ophir Gottlieb
The double-edged sword of growth-stock speculation 2:30 p.m. Nov. 14, 2014 - The Trading Deck
Two biotech leaders to watch 1:13 p.m. Oct. 28, 2014 - The Trading Deck
Celgene profit up 37%, raises outlook 7:42 a.m. Oct. 23, 2014 - MarketWatch.com
Be ready to play another market surge 11:25 a.m. Sept. 19, 2014 - The Trading Deck
14 stocks loved by top-performing fund managers 5:49 a.m. Sept. 18, 2014 - Philip van Doorn
Lululemon surges; RadioShack rebounds 2:24 p.m. Sept. 11, 2014 - Sue Chang
Major U.S. benchmarks rattle cage on first support 10:06 a.m. Sept. 10, 2014 - Michael Ashbaugh

After CAR-T: Getting Ahead of the Next Hot Trend in Cancer Stocks 8:30 a.m. Today - TheStreet.com
Fifteen Fabulously Intelligent Biotech Stock Predictions for 2015 8:30 a.m. Today - TheStreet.com
Making Celgene A Core Holding Should Be Better Than Trading In And Out Of It 8:19 a.m. Today - Seeking Alpha
My 2014 Best Performers, Looking Ahead To 2015 7:34 a.m. Today - Seeking Alpha
Cramer Says Wells Fargo Is a Buy; Wait for a Regeneron Pullback 11:21 a.m. Jan. 5, 2015 - TheStreet.com
Cellectis Is Late To The CAR-T Cell Race, But Could Finish First 4:21 p.m. Jan. 2, 2015 - Seeking Alpha
An Investor's Guide: Market-Leading Industries In 2014 1:57 p.m. Jan. 2, 2015 - Investors Business Daily
Individual Investor Portfolio: Solid Results, But Energy Sell-Off And Biotechnology Add Volatility 10:45 a.m. Jan. 2, 2015 - Seeking Alpha
5 Massive Upside Stocks for 2015 8:42 a.m. Jan. 1, 2015 - 247WallSt.com
5 Biotech Stocks With Big News Due In January 12:15 p.m. Dec. 31, 2014 - Investors Business Daily
Jim Cramer's 'Mad Money' Recap: How to Become an Even Better Investor 7:00 p.m. Dec. 30, 2014 - TheStreet.com
Will Biotech Fire On All Cylinders In 2015? 4:15 p.m. Dec. 30, 2014 - Seeking Alpha
DoctoRx Positions For 2015: I Have Cut Back On My Exposure To All Biotech Substantially 7:05 a.m. Dec. 30, 2014 - Seeking Alpha
Gilead Sciences: After The Bloodbath The Stock Is A Strong Buy 2:52 p.m. Dec. 29, 2014 - Seeking Alpha
Biotech-Twitter 2014: A Look Back at the Biotech Year Through the Twitter Lens 6:00 a.m. Dec. 29, 2014 - TheStreet.com
2 New Funds Add a New Twist to Biotech Stocks 4:47 a.m. Dec. 29, 2014 - InvestorPlace.com
IBD 50: Biotechs Hammered, Then Find Support 5:27 p.m. Dec. 26, 2014 - Investors Business Daily
Stock Market News for December 26, 2014 - Market News 10:10 a.m. Dec. 26, 2014 - Zacks.com
4 Biotech Stocks that Doubled in 2014 - Analyst Blog 9:00 a.m. Dec. 26, 2014 - Zacks.com
Celgene Corporation (CELG): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report 7:00 a.m. Dec. 26, 2014 - Zacks.com

Biotechs to Follow in 2015 off Fresh Insider Moves 43 min ago - ACCESSWIRE
Celgene Corporation to Present at the 33rd Annual J.P. Morgan Healthcare Conference 8:31 a.m. Today - BusinessWire - BZX
Critical Alerts For Invensense, FireEye, General Electric, Twitter and Celgene Released By InvestorsObserver 9:31 a.m. Dec. 22, 2014 - PR Newswire - PRF
Scanning Biotech Equities -- Celgene, Novavax, Amarin, Immunomedics, and Aeterna Zentaris 8:40 a.m. Dec. 17, 2014 - PR Newswire - PRF
Data Presented on REVLIMID® (lenalidomide) Compared with Investigators’ Choice in Relapsed/Refractory Diffuse Large B-Cell Lymphoma 8:34 p.m. Dec. 8, 2014 - BusinessWire - BZX
Additional Analyses of High-Risk Patients from Phase III Study (AML-001) OF Vidaza® (Azacitidine for Injection) in Acute Myeloid Leukemia Presented at ASH 8:33 p.m. Dec. 8, 2014 - BusinessWire - BZX
REVLIMID® (Lenalidomide) Single-Agent and Combination Studies in Mantle Cell Lymphoma (MCL) Presented at ASH 8:33 p.m. Dec. 8, 2014 - BusinessWire - BZX
New Data in Myelodysplastic Syndromes Presented at the 56th American Society of Hematology (ASH) Annual Meeting and Exposition 2:00 p.m. Dec. 8, 2014 - BusinessWire - BZX
Results from Phase III Study of REVLIMID® (Lenalidomide) Demonstrating Improved Transfusion Independence in Patients with Rare Blood Cancer, Non-Del-5Q Myelodysplastic Syndromes (MDS), Presented at ASH 1:49 p.m. Dec. 8, 2014 - BusinessWire - BZX
Age, Renal Impairment and Depth of Response Analyses of the FirstTM (MM-020/IFM 07-01)Study of Continuous REVLIMID® (lenalidomide) Plus Low-Dose dexamethasone in Newly-Diagnosed Multiple Myeloma Presented at ASH 9:58 p.m. Dec. 7, 2014 - BusinessWire - BZX
Critical Alerts For Noodles & Company, Goldcorp, YY, Celgene and LinkedIn Released By InvestorsObserver 9:31 a.m. Dec. 2, 2014 - PR Newswire - PRF
Celgene Recommends Shareholders Reject “Mini-Tender” Offer by TRC Capital Corporation 4:30 p.m. Dec. 1, 2014 - BusinessWire - BZX
Celgene Receives Positive CHMP Opinion for OTEZLA® (apremilast), the First Oral PDE4 Inhibitor for the Treatment of Patients with Psoriasis and Psoriatic Arthritis 6:00 a.m. Nov. 21, 2014 - BusinessWire - BZX
Chef Michael Ferraro, the Pancreatic Cancer Action Network and Meals to Heal Team up with Celgene to Address Nutritional Needs and Challenges Faced by Pancreatic Cancer Patients and Caregivers 8:00 a.m. Nov. 20, 2014 - BusinessWire - BZX
UPDATE: Bionor Pharma Announces That the Combination of Vacc-4x + Revlimid(R) Is Well Tolerated and Increases CD4 Counts in People Living With HIV 4:29 p.m. Nov. 19, 2014 - Marketwired
Bionor Pharma Announces That the Combination of Vacc-4x + Revlimid(R) Is Safe and Increases CD4 Counts in People Living With HIV 3:35 p.m. Nov. 19, 2014 - Marketwired
Oral OTEZLA® (Apremilast) Showed Sustained Clinical Response over Two Years in Patients with Active Psoriatic Arthritis 7:30 a.m. Nov. 18, 2014 - BusinessWire - BZX
Moffitt Cancer Center Announces Development of Experimental Treatment for Myelodysplastic Syndromes, Autoimmune Diseases 9:03 a.m. Nov. 17, 2014 - BusinessWire - BZX
Equity Coverage on Biotech Industry - Gilead Sciences, MannKind, ARIAD Pharma, iBio Inc., and Celgene 9:10 a.m. Nov. 14, 2014 - PR Newswire - PRF
Quarterly Financial Performance Reviews, Upcoming Events, and Medicare Plan Launch - Research Reports on Actavis, Celgene, UnitedHealth, Jazz and Endo 8:50 a.m. Nov. 10, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Sinopec's Catalyst Conference: Driving Global Innovation

The Role of Catalysts in Modern Industry Swing by any bustling industrial hub, and you're likely to catch talk about catalysts—unsung heroes that make the machinery of modern industry run smoother, faster, and cleaner. Over in Tianjin, China, Sinopec just wrapped up its Second International Catalyst Customer Conference, which is less of a tongue-twister than it sounds....

Canton Fair 2026: Tech and Tradition Transform Jewelry

Tech-Savvy Elegance at Canton Fair Dive into the glitz and glamour of the jewelry zone at the 140th Canton Fair, where technology and craftsmanship are forging a new narrative for luxury accessories. This isn’t just your grandmother’s jewelry box we're talking about anymore. We’re witnessing the dawn of precious metal smart rings and dual-band smart watches that...

Flagstar Faces Heat: 9.2% Stock Drop Spurs Probe

Flagstar's Descent: What Led to the Stock Tumble? And here we go again with a big name in finance taking a hit right between the eyes. Flagstar Bank, under ticker NYSE:FLG, saw its shares plummet by over 9.2% on October 23, 2026. This isn't just a blip—it's a spill. The backdrop here is an eye-watering $12.9 billion loan book tied to rent-regulated apartment buildings....

Nucor's Q3 2026 Earnings: Strong Growth Amid Steel Surge

Nucor's Solid Third Quarter Performance Nucor Corporation is flexing its muscles, reporting a robust third quarter for 2026. With net earnings hitting $1.32 billion and a diluted earnings per share of $5.80, the steel giant has shown it can more than hold its ground in a competitive market. Compare that to last quarter's $1.16 billion - we're seeing serious momentum....

Greenhouse and Planetarium Revamp Enrich Florida Southern

A Celebration of Science and Heritage In an era where institutions are either scaling back or going digital, Florida Southern College is doubling down on its roots and looking skyward. On October 22, 2026, the campus buzzed with a celebration that would have done any investor in education and heritage proud—raising the Ben and Missy Albritton Citrus and Horticulture...

Canton Fair: More Than Trade—A Cultural Exchange

Why a Trade Fair Needs Lion Dances October 2026 marks a time when talking about a trade fair means diving headfirst into a whirlpool of global exchange and cultural tango we don’t often see in the West. Yeah, I'm looking at you, Canton Fair—a long-runner over in China that's managed to haul in the globe to not just showcase wares, but bring people together in a clash...

Innventure Faces Legal Scrutiny Over DarkNX Debacle

Innventure’s Market Tumult: Unraveling the Drama Talk about a mess. Innventure Inc. (NASDAQ: INV) investors are likely feeling a sting sharper than a bee that's lost its hive after a painful 55% stock crash back in August 2026. The culprit? A scuttled project involving a shadowy partner, DarkNX, and a lot of questions about who knew what and when. A Puzzling...

Essential Oils Market Booms; Hits $29.52Bn by 2031

Essential Oils: Aromatherapy's New Frontier and Pharma Ally What’s the deal with essential oils? Well, it seems they’re not just for your neighbor’s pricey diffuser anymore. According to some fresh numbers, we're staring down a market worth nearly $30 billion by 2031. And it ain't all incense and hippie stores fueling this beast — we're talking a serious expansion...

Key Sewer Line Damage Signs Homeowners Often Ignore

Spotting Trouble Beneath the Surface Now, when was the last time you eyeballed your home’s plumbing with more than a passing glance? Most folks don’t give their sewer lines two thoughts until something foul pops up. Plumbing expert Jessica Gerdeman from Heggemann, Inc. in Warrenton, Missouri, isn’t just blowing hot air when she points out the indicators of looming...

Thanksgiving Relief: Alabama Firm Offers $200 Gift Cards

A Firm's Gratitude with a Dash of Holiday Cheer It takes more than just legal prowess to make waves in a community. Tyler Mann Injury Law is stepping outside the courtroom to bring some warmth to Alabama families this Thanksgiving. They're hosting a giveaway that puts a little financial relief where it counts—at the Thanksgiving dinner table, straightening out the...